These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 142260)

  • 41. Nicotinic acid in the treatment of schizophrenias. Canadian Mental Health Association collaborative study: progress report II.
    Ban TA; Lehmann HE
    Can Psychiatr Assoc J; 1975 Mar; 20(2):103-12. PubMed ID: 1100217
    [No Abstract]   [Full Text] [Related]  

  • 42. A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients.
    Small JG; Kellams JJ; Milstein V; Moore J
    Am J Psychiatry; 1975 Dec; 132(12):1315-7. PubMed ID: 1106217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenics.
    Ananth JV; Ban TA; Lehmann HE; Bennett J
    Can Psychiatr Assoc J; 1970 Feb; 15(1):15-20. PubMed ID: 4906138
    [No Abstract]   [Full Text] [Related]  

  • 44. Antipsychotic effects of lithium in schizophrenia.
    Alexander PE; van Kammen DP; Bunney WE
    Am J Psychiatry; 1979 Mar; 136(3):283-7. PubMed ID: 369396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of naloxone in chronic schizophrenia.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Am J Psychiatry; 1981 Jul; 138(7):913-8. PubMed ID: 6266259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride.
    Kurland AA; McCabe OL; Hanlon TE; Sullivan D
    Am J Psychiatry; 1977 Dec; 134(12):1408-10. PubMed ID: 335903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical comparison of oxyprothepin and clotepine in schizophrenic patients (controlled study).
    Náhunek K; Svestka J; Cesková E; Rysánek R
    Act Nerv Super (Praha); 1979 Oct; 21(3):133-5. PubMed ID: 42259
    [No Abstract]   [Full Text] [Related]  

  • 48. Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics.
    Ananth JV; Ban TA; Lehmann HE
    Can Psychiatr Assoc J; 1973 Oct; 18(5):377-83. PubMed ID: 4147710
    [No Abstract]   [Full Text] [Related]  

  • 49. Nicotinic acid in the treatment of schizophrenias. Practical and theoretical considerations.
    Ban TA
    Neuropsychobiology; 1975; 1(3):133-45. PubMed ID: 8743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A search for responders to niacin supplementation.
    Wittenborn JR
    Arch Gen Psychiatry; 1974 Oct; 31(4):547-52. PubMed ID: 4607587
    [No Abstract]   [Full Text] [Related]  

  • 51. Interferon-alpha as adjuvant treatment in chronic schizophrenia.
    Katila H; Cantell C; Appelberg B; Wahlbeck K; Naukkarinen H; Rimón R
    Neuropsychobiology; 1993; 28(4):192-6. PubMed ID: 8272201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A clinical trial of leptazole with nicotinic acid in the management of psycho-geriatric patients.
    Gabrynowicz JW; Dumbrill M
    Med J Aust; 1968 May; 1(19):799-802. PubMed ID: 4872367
    [No Abstract]   [Full Text] [Related]  

  • 53. Letter: Megavitamin treatment in schizophrenia.
    Hoffer J
    Can Psychiatr Assoc J; 1976 Mar; 21(2):133-4. PubMed ID: 776387
    [No Abstract]   [Full Text] [Related]  

  • 54. Nicotinic acid therapy and the chronic schizophrenic.
    O'REILLY PO
    Dis Nerv Syst; 1955 Mar; 16(3):67-72. PubMed ID: 14365579
    [No Abstract]   [Full Text] [Related]  

  • 55. Nicotinic acid and psychiatry.
    Ban TA
    Can Psychiatr Assoc J; 1971 Oct; 16(5):413-31. PubMed ID: 4948811
    [No Abstract]   [Full Text] [Related]  

  • 56. Nicotinic acid, thioridazine, fluoxymesterone and their combinations in hospitalized geriatric patients: a systematic clinical study.
    Lehmann HE; Ban TA; Saxena BM
    Can Psychiatr Assoc J; 1972 Aug; 17(4):315-20. PubMed ID: 4565508
    [No Abstract]   [Full Text] [Related]  

  • 57. Therapy and clinical trials: nicotinic acid in the management of atherosclerotic disease.
    Udiawar MV; Rees A
    Curr Opin Lipidol; 2010 Jun; 21(3):286-8. PubMed ID: 20463477
    [No Abstract]   [Full Text] [Related]  

  • 58. Niacin and the schizophrenic patient.
    Newbold HL; Mosher LR
    Am J Psychiatry; 1970 Oct; 127(4):535-6. PubMed ID: 4248216
    [No Abstract]   [Full Text] [Related]  

  • 59. Experimentally controlled evaluation of vasoactive drugs in digital ischemia.
    Holti G
    Angiology; 1978 Jan; 29(1):89-94. PubMed ID: 343655
    [No Abstract]   [Full Text] [Related]  

  • 60. Negative findings with nicotinic acid in the treatment of schizophrenias.
    Ban TA
    Int Pharmacopsychiatry; 1974; 9(3):172-87. PubMed ID: 4430570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.